CBD

In honor of National CBD Day on August 8, 2025, we are excited to share with you our CBD-themed round up of CBD research.

In honor of National CBD Day on August 8, 2025, we are excited to share with you our CBD-themed round up of CBD-related medical research.

Check out our exciting 2025 National CBD Day coverage!

Analysis of two coffee products revealed 70–80% less CBD in the brewed coffee than what was indicated on the label.

Data from a recent study discovered that THC labeling was more accurate in concentrate products than with cannabis flower.

Here, we bring you our top five recent articles covering medical cannabis in Texas, cease-and-desist letter response, pardons in Maryland, cannabis in Thailand, and research on autism and cannabis.

Results included improvements in aggression, hyperactivity, and communication, but a strong placebo effect was also observed.

A recent study found that CBD gummies may not have accurate labeling on how much the cannabinoid it contains.

The cannabinoids cannabidiol (CBD) and cannabidivarin (CBDV) showed antifungal activity in both in vivo tests and in vitro wound models.

A recent study highlighted potential benefits for CBD to provide relief from chronic pain.

Topically applied cannabinoids such as CBD and THC may offer significant benefits for people experiencing localized pain and dermatological conditions. This article explores these potential benefits as well as their mechanisms.

A recent study explored how vaporized cannabis consisting of a standardized THC and CBD formulation may help improve symptoms of MS patients.

The ointment containing CBD and CBG was evaluated for its effect on improvements in symptoms after an eight week period.

The study tested the effects of the pillowcases on the sleep quality and sleep duration in nurses, also testing for effects on mood and anxiety.

Researchers developed a CBD–phospholipid complex to enhance solubility, permeability, and bioavailability.

The two new CBD pet products are aimed at supporting aging pets with arthritis, anxiety, and reactivity.

Industry feedback is being considered in developing pathways to make CBD accessible – and safe – to treat minor health conditions without a prescription.

Researchers found CBD improved muscle endurance, mitochondrial function, and oxidative capacity, and more, with effects eliminated by antibiotics.

The survey analyzed responses from CBD users and non-CBD users on their symptoms and quality of life.

A study involving older adults revealed correlation between CBD use and health issues.

The study aimed to evaluate short-term, repeated use of low dose CBD and intense exercise.

Researchers examined a half-dozen medical records involving CBD used to treat THC toxicosis in dogs.

This article examines what rescheduling cannabis would involve, the implications for various sectors, and the potential roadblocks that could arise along the way.

Here, Scott Mazza, Founder of Vitality CBD, discusses applying cannabidiol (CBD) in pets.

The five-year study will be supported by a $2.2 million grant from the National Institute of Drug Abuse.

The researchers point out that it is important for clinicians to ask about CBD use to better advise patients and prevent potential drug interactions.

The study found improvement in symptom relief with participants who used the suppositories, compared to the treatment-as-usual group.

A recent study targeting mild to moderate anxiety disorders showed that oral CBD can be a safe, effective treatment option.

This article provides an analysis of current regulations and proposed changes that could impact the hemp industry.

One study analyzed nearly 100 CBD products to test the accuracy of advertised cannabinoid content.